Faculty

Kyla M. Lara-Breitinger, M.D., M.S.

Clinical Studies

Ketogenic Intervention for Bipolar Depression: An Open-Label Trial Guiding Clinical Implementation (KETO-BD) Rochester, MN
The purpose of this study to assess the clinical correlates of therapeutic precision ketosis in bipolar depression and to evaluate the cardiometabolic correlates associated with therapeutic precision ketosis in bipolar depression.

Mayo Obesity And Coronary Interventions (MOCI): Characterizing Obesity Phenotypes To Improve Outcomes After Percutaneous Coronary Intervention And Coronary Artery Bypass Grafting Rochester, MN
The purpose of this study is to evaluate clinical outcomes (e.g., mortality, major adverse cardiovascular events [MACE], hospital readmissions) among obese patients undergoing Percutaneous Coronary Intervention (PCI) or Coronary Artery Bypass Grafting (CABG), stratified by BMI.
Mayo Obesity And Valvular Interventions (MOVI): Characterizing Obesity Phenotypes To Improve Outcomes After Transcatheter Aortic, Mitral, And Tricuspid Valve Interventions Rochester, MN
The purpose of this study is to To evaluate clinical outcomes mortality, hospital readmissions, procedural complications) among obese patients undergoing Transcatheter Aortic Valve Replacement (TAVR) stratified by BMI.
The Weight Of Cardiovascular Disease: A Prospective Pilot Study Of Obese Adults With Cardiovascular Disease Evaluated In A Novel Cardiometabolic Clinic Rochester, MN
The purpose of this study is to evaluate the impact of a cardiometabolic clinic on percent body weight loss, body mass index (BMI), and visceral adiposity distribution in obese adults with cardiovascular disease (CVD) at 6 months.

The Weight Of Cardiovascular Disease: A Prospective Pilot Study Of Obese Adults With Cardiovascular Disease Evaluated In A Novel Cardiometabolic Clinic Rochester, MN
The purpose of this study is to evaluate the impact of a cardiometabolic clinic on percent body weight loss, body mass index (BMI), and visceral adiposity distribution in obese adults with cardiovascular disease (CVD) at 12 months.